ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

KRMD vs SKYA // ALTMAN Z-SCORE & DEBT/EQUITY

KORU Medical Systems Inc. (NASDAQ) VS. SkyAI Inc. (NASDAQ) • 15-METRIC TALLY: KRMD 7 — SKYA 2
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: SKYA
balance-sheet
11.30
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KRMD VS. SKYA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC KRMD SKYA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 62.30% -30.00% +92.30 KRMD /gross-margins <GO>
Return on Invested Capital (ROIC) -28.70% -35.00% +6.30 KRMD /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield 0.31% -8.67% +8.98 KRMD /fcf-yield <GO>
Operating Margin -7.20% -60.00% +52.80 KRMD /operating-margins <GO>
Net Profit Margin -6.40% -60.00% +53.60 KRMD /net-margins <GO>
Revenue Growth (YoY) 22.20% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE 8.05 11.30 -3.25 SKYA /balance-sheet <GO>
Piotroski F-Score Quality 7/9 2/9 +5.00 KRMD /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 55.8 74.0 -18.20 SKYA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $149.1M $126.7M $22.4M KRMD /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR KRMD REV SKYA REV KRMD GROSS % SKYA GROSS % KRMD FCF SKYA FCF
FY 2025 $41.1M $204.1K 62.3% -50.0% $462.4K -$11.0M
FY 2024 $33.6M $0 63.4% — -$319.7K -$4.5M
FY 2023 $28.5M $0 — — -$4.9M -$8.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KRMD // BETA —
SKYA // BETA —